WBA
44
3
CHD
40
-2
HBI
64
12
GD
49
-3
KR
57
-3
FIS
62
-3
IPG
31
-12
MUR
33
2
IFF
44
-4
HSIC
51
-3
SO
68
-2
M
39
5
FOX
53
-4
NEE
47
-10
DTE
49
-5
CNP
62
10
AMG
47
-2
SIG
40
2
PNW
59
-3
SYK
46
-2
WBA
44
3
CHD
40
-2
HBI
64
12
GD
49
-3
KR
57
-3
FIS
62
-3
IPG
31
-12
MUR
33
2
IFF
44
-4
HSIC
51
-3
SO
68
-2
M
39
5
FOX
53
-4
NEE
47
-10
DTE
49
-5
CNP
62
10
AMG
47
-2
SIG
40
2
PNW
59
-3
SYK
46
-2
Financhill
Back

Professional Diversity Network Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
15

IPDN
Professional Diversity Network

Last Price:
$1.56
Seasonality Move:
-12.48%
Buy
65

HALO
Halozyme Therapeutics

Last Price:
$54.54
Seasonality Move:
2.09%
Sell
15
Professional Diversity Network (IPDN) is a Sell

Is Professional Diversity Network a Buy, Sell or Hold?

  • The current Professional Diversity Network [IPDN] share price is $1.49. The Score for IPDN is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • IPDN is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
65
Halozyme Therapeutics (HALO) is a Buy

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $53.75. The Score for HALO is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • HALO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

IPDN Stock Price Chart

What is Professional Diversity Network's stock price today?

  • The Professional Diversity Network share price today is $1.49
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IPDN is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $53.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing slight buying pressure.

IPDN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 44 Sell
Chaikin Money Flow: -1252 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.32 - 1.72) Sell
Bollinger Bands (100): (1.55 - 3.99) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.15 Sell
Relative Strength Index (14 RSI): 42.85 Sell
Chaikin Money Flow: 338733 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.79 - 64.03) Sell
Bollinger Bands (100): (53.07 - 62.71) Sell

IPDN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.55 Sell
20-day SMA: 1.6 Sell
50-day SMA: 1.77 Sell
200-day SMA: 4.55 Sell
8-day EMA: 1.54 Sell
20-day EMA: 1.58 Sell
50-day EMA: 1.93 Sell
200-day EMA: 5.03 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 51.69 Buy
20-day SMA: 58.42 Sell
50-day SMA: 60.23 Sell
200-day SMA: 56.31 Sell
8-day EMA: 54.29 Sell
20-day EMA: 56.83 Sell
50-day EMA: 58.43 Sell
200-day EMA: 55.33 Sell

Professional Diversity Network Earnings Growth & IPDN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.06 per share, an increase this year of $1.19 per share, and an increase next year of $1.27 per share.

Professional Diversity Network Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):